Table 3.
Distribution of HR-HPV types according to cervical intraepithelial neoplasia
| CC | CINI | CINII/CINIII | Total | |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||
| HPV16 | 9 (24.3%) | 21 (56.7%) | 7 (18.9%) | 37 |
| HPV18 | 8 (53.3%) | 2 (13.3%) | 5 (33.3%) | 15 |
| HPV31 | 0 (0.0%) | 7 (100.0%) | 0 (0.0%) | 7 |
| HPV33 | 0 (0.0%) | 2 (100.0%) | 0 (0.0%) | 2 |
| HPV35 | 2 (25%) | 3 (37.5%) | 3 (37.5%) | 8 |
| HPV39 | 0 (0.0%) | 5 (100.0%) | 0 (0.0%) | 5 |
| HPV45 | 4 (57.5%) | 1 (14.2%) | 2 (28.5%) | 7 |
| HPV51 | 0 (0.0%) | 5 (83.3%) | 1 (16.6%) | 6 |
| HPV52 | 0 (0.0%) | 3 (100.0%) | 0 (0.0%) | 3 |
| HPV53 | 3 (37.5%) | 5 (62.5%) | 0 (0.0%) | 8 |
| HPV56 | 0 (0.0%) | 1 (100.0%) | 0 (0.0%) | 1 |
| HPV58 | 2 (100.0%) | 0 (0.0%) | 0 (0.0%) | 2 |
| HPV59 | 3 (100.0%) | 0 (0.0%) | 0 (0.0%) | 3 |
| HPV66 | 2 (50.0%) | 2 (50.0%) | 0 (0.0%) | 4 |
| HPV68 | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | 1 |
| HPV70 | 0 (0.0%) | 3 (100.0%) | 0 (0.0%) | 3 |
CINI cervical intraepithelial neoplasia I, CINII cervical intraepithelial neoplasia II, CINIII cervical intraepithelial neoplasia III